PubRank

Hai-Liang Zhu

Author PubWeight™ 135.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Synthesis and antimicrobial activities of Schiff bases derived from 5-chloro-salicylaldehyde. Eur J Med Chem 2006 2.78
2 Enamines as novel antibacterials and their structure-activity relationships. Eur J Med Chem 2007 2.65
3 Synthesis, structure, and structure-activity relationship analysis of enamines as potential antibacterials. Bioorg Med Chem 2007 2.29
4 Synthesis, molecular modeling, and biological evaluation of cinnamic acid metronidazole ester derivatives as novel anticancer agents. Bioorg Med Chem 2010 2.25
5 Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease. Bioorg Med Chem 2007 2.13
6 Synthesis and cytotoxic evaluation of a series of resveratrol derivatives modified in C2 position. Eur J Med Chem 2006 1.65
7 Synthesis, antiproliferative activity, and structure-activity relationships of 3-aryl-1H-quinolin-4-ones. ChemMedChem 2008 1.64
8 Metronidazole-flavonoid derivatives as anti-Helicobacter pylori agents with potent inhibitory activity against HPE-induced interleukin-8 production by AGS cells. ChemMedChem 2007 1.62
9 Synthesis, molecular docking and biological evaluation of Schiff base transition metal complexes as potential urease inhibitors. Eur J Med Chem 2010 1.61
10 Synthesis, crystal structure and antimicrobial activity of deoxybenzoin derivatives from genistein. Eur J Med Chem 2007 1.57
11 Selective fluorescent probes for live-cell monitoring of sulphide. Nat Commun 2011 1.51
12 Synthesis, antiproliferative evaluation, and structure-activity relationships of 3-arylquinolines. ChemMedChem 2008 1.50
13 Synthesis, structure, molecular docking, and structure-activity relationship analysis of enamines: 3-aryl-4-alkylaminofuran-2(5H)-ones as potential antibacterials. Bioorg Med Chem 2011 1.44
14 Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors. Eur J Med Chem 2013 1.40
15 Schiff base transition metal complexes as novel inhibitors of xanthine oxidase. Eur J Med Chem 2007 1.36
16 Synthesis of some N-alkyl substituted urea derivatives as antibacterial and antifungal agents. Eur J Med Chem 2010 1.33
17 Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line. Eur J Med Chem 2010 1.23
18 Synthesis, structure and antibacterial activity of new 2-(1-(2-(substituted-phenyl)-5-methyloxazol-4-yl)-3-(2-substitued-phenyl)-4,5-dihydro-1H-pyrazol-5-yl)-7-substitued-1,2,3,4-tetrahydroisoquinoline derivatives. Bioorg Med Chem 2008 1.20
19 The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors. Eur J Med Chem 2010 1.20
20 Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents. Eur J Med Chem 2011 1.18
21 Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents. Eur J Med Chem 2009 1.17
22 Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Bioorg Med Chem Lett 2011 1.14
23 Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors. Bioorg Med Chem 2009 1.14
24 Synthesis and cytotoxic evaluation of a series of genistein derivatives. Chem Biodivers 2006 1.14
25 Synthesis of resveratrol analogues, and evaluation of their cytotoxic and xanthine oxidase inhibitory activities. Chem Biodivers 2008 1.13
26 Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones. Eur J Med Chem 2011 1.12
27 Synthesis and antimicrobial activities of 7-O-modified genistein derivatives. Eur J Med Chem 2007 1.10
28 Curcumin and its formulations: potential anti-cancer agents. Anticancer Agents Med Chem 2012 1.08
29 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation. Bioorg Med Chem 2011 1.07
30 Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. Bioorg Med Chem 2010 1.07
31 Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea. Bioorg Med Chem 2011 1.06
32 catena-Poly[[[2,4-dichloro-6-(pyridin-2-ylmethyliminomethyl)phenolato]copper(II)]-mu-thiocyanato]. Acta Crystallogr C 2005 1.05
33 catena-Poly[[[mu-pyrazine-kappa2N:N'-disilver(I)]-di-mu-pyrazine-kappa4N:N'] bis(trifluoromethanesulfonate) dihydrate]. Acta Crystallogr C 2004 1.05
34 Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents. Eur J Med Chem 2010 1.04
35 Synthesis, structure and antibacterial activity of novel 1-(5-substituted-3-substituted-4,5-dihydropyrazol-1-yl)ethanone oxime ester derivatives. Bioorg Med Chem 2008 1.01
36 1,3,4-oxadiazole derivatives as potential biological agents. Mini Rev Med Chem 2013 1.00
37 Synthesis and cytotoxic evaluation of a series of resveratrol derivatives. Chem Biodivers 2006 0.99
38 Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors. Bioorg Med Chem 2009 0.97
39 Urea derivatives as anticancer agents. Anticancer Agents Med Chem 2009 0.95
40 Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics. Bioorg Med Chem 2009 0.93
41 Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents. Bioorg Med Chem 2011 0.93
42 Resveratrol and its analogues: promising antitumor agents. Anticancer Agents Med Chem 2011 0.93
43 1,3,4-Thiadiazole: synthesis, reactions, and applications in medicinal, agricultural, and materials chemistry. Chem Rev 2014 0.89
44 Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents. Bioorg Med Chem 2011 0.89
45 Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. Bioorg Med Chem 2011 0.89
46 Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents. Eur J Med Chem 2008 0.88
47 Synthesis, biological evaluation, and molecular modeling of cinnamic acyl sulfonamide derivatives as novel antitubulin agents. Bioorg Med Chem 2011 0.87
48 Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents. Bioorg Med Chem 2013 0.87
49 Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents. Bioorg Med Chem 2012 0.87
50 Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Eur J Med Chem 2012 0.86
51 Synthesis and cytotoxic evaluation of substituted urea derivatives as inhibitors of human-leukemia K562 cells. Chem Biodivers 2007 0.85
52 Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents. Bioorg Med Chem Lett 2010 0.85
53 Structure and total synthesis of aspernigerin: a novel cytotoxic endophyte metabolite. Chemistry 2006 0.85
54 catena-Poly[[silver(I)-mu-ethane-1,2-diamine-kappa2N:N'] trifluoromethanesulfonate]. Acta Crystallogr C 2004 0.85
55 Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents. Bioorg Med Chem 2011 0.84
56 Hydrogen-bond-mediated cascade reaction involving chalcones: facile synthesis of enantioenriched trisubstituted tetrahydrothiophenes. Org Lett 2012 0.84
57 Polycyclic aromatic hydrocarbons and ecotoxicological characterization of sediments from the Huaihe River, China. J Environ Monit 2011 0.83
58 Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents. Bioorg Med Chem 2012 0.83
59 Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents. Bioorg Med Chem Lett 2011 0.83
60 Synthesis and molecular docking studies of novel 2-chloro-pyridine derivatives containing flavone moieties as potential antitumor agents. Bioorg Med Chem Lett 2010 0.83
61 Synthesis and antioxidant activity of novel Mannich base of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan. Bioorg Med Chem 2013 0.83
62 The combination of 4-anilinoquinazoline and cinnamic acid: a novel mode of binding to the epidermal growth factor receptor tyrosine kinase. Bioorg Med Chem 2011 0.83
63 Synthesis and cytotoxic evaluation of novel 7-O-modified genistein derivatives. Chem Biodivers 2007 0.83
64 Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents. Bioorg Med Chem Lett 2012 0.82
65 Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent. Eur J Med Chem 2012 0.82
66 Novel 1,3,4-oxadiazole thioether derivatives targeting thymidylate synthase as dual anticancer/antimicrobial agents. Bioorg Med Chem 2013 0.81
67 Design, synthesis and biological evaluation of novel chalcone derivatives as antitubulin agents. Bioorg Med Chem 2012 0.81
68 Optimization of substituted 6-salicyl-4-anilinoquinazoline derivatives as dual EGFR/HER2 tyrosine kinase inhibitors. PLoS One 2013 0.81
69 Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics. Bioorg Med Chem 2009 0.81
70 Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors. Bioorg Med Chem 2012 0.81
71 Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors. Bioorg Med Chem Lett 2010 0.81
72 Genistein and its synthetic analogs as anticancer agents. Anticancer Agents Med Chem 2012 0.81
73 Molecular docking, kinetics study, and structure-activity relationship analysis of quercetin and its analogous as Helicobacter pylori urease inhibitors. J Agric Food Chem 2012 0.81
74 Design, synthesis and biological evaluation of novel (E)-α-benzylsulfonyl chalcone derivatives as potential BRAF inhibitors. Eur J Med Chem 2012 0.81
75 Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors. Bioorg Med Chem Lett 2012 0.80
76 Adsorbable organic halogens generation and reduction during degradation of phenol by UV radiation/sodium hypochlorite. Water Environ Res 2009 0.80
77 Metronidazole-deoxybenzoin derivatives as anti-Helicobacter pylori agents with potent inhibitory activity against HPE-induced interleukin-8. ChemMedChem 2010 0.80
78 Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents. Bioorg Med Chem 2010 0.80
79 Squaramide-catalyzed enantioselective Friedel-Crafts reaction of indoles with imines. Chem Commun (Camb) 2010 0.80
80 Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents. Bioorg Med Chem 2012 0.80
81 Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors. Bioorg Med Chem 2012 0.80
82 Design, synthesis, biological evaluation, and molecular modeling study of 4-alkoxyquinazoline derivatives as potential VEGFR2 kinase inhibitors. Org Biomol Chem 2013 0.80
83 Treatment of simulated wastewater containing Reactive Red 195 by zero-valent iron/activated carbon combined with microwave discharge electrodeless lamp/sodium hypochlorite. J Environ Sci (China) 2010 0.79
84 Hypolipidemic activity in Sprague-Dawley rats and constituents of a novel natural vegetable oil from Cornus wilsoniana fruits. J Food Sci 2012 0.79
85 Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity. Bioorg Med Chem 2011 0.79
86 Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors. Bioorg Med Chem Lett 2013 0.79
87 Novel 2,4,5-trisubstituted oxazole derivatives: synthesis and antiproliferative activity. Eur J Med Chem 2009 0.79
88 Synthesis, biological evaluation, and molecular docking studies of 2,6-dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime derivatives as novel antitubulin agents. Bioorg Med Chem 2012 0.79
89 Degradation of Active Brilliant Red X-3B by a microwave discharge electrodeless lamp in the presence of activated carbon. Environ Technol 2010 0.79
90 Design, synthesis and biological evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors. Bioorg Med Chem Lett 2010 0.78
91 A functional scaffold in marine alkaloid: an anticancer moiety for human. Curr Med Chem 2013 0.78
92 Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents. Bioorg Med Chem 2009 0.78
93 Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents. Bioorg Med Chem 2009 0.78
94 Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity. Bioorg Med Chem 2012 0.78
95 Design, synthesis and structure-activity relationships of antiproliferative 1,3-disubstituted urea derivatives. Eur J Med Chem 2008 0.78
96 Synthesis, biological evaluation and 3D-QSAR studies of novel 4,5-dihydro-1H-pyrazole niacinamide derivatives as BRAF inhibitors. Bioorg Med Chem 2012 0.78
97 Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents. Bioorg Med Chem 2012 0.78
98 Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors. Bioorg Med Chem Lett 2014 0.78
99 Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials. Eur J Med Chem 2008 0.78
100 Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors. Eur J Med Chem 2013 0.78
101 Design, modification and 3D QSAR studies of novel 2,3-dihydrobenzo[b][1,4]dioxin-containing 4,5-dihydro-1H-pyrazole derivatives as inhibitors of B-Raf kinase. Bioorg Med Chem 2012 0.78
102 Discovery of 1H-benzo[d][1,2,3]triazol-1-yl 3,4,5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase. Bioorg Med Chem 2010 0.78
103 Synthesis and antifungal activity of nicotinamide derivatives as succinate dehydrogenase inhibitors. J Agric Food Chem 2014 0.77
104 Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors. Bioorg Med Chem Lett 2012 0.77
105 Synthesis of novel cinnamanilides as potential immunosuppressive agents. Eur J Med Chem 2011 0.77
106 Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents. ChemMedChem 2013 0.77
107 Novel FabH inhibitors: a patent and article literature review (2000--2012). Expert Opin Ther Pat 2012 0.77
108 Amines and oximes derived from deoxybenzoins as Helicobacter pylori urease inhibitors. Eur J Med Chem 2008 0.77
109 Novel depsides as potential anti-inflammatory agents with potent inhibitory activity against Escherichia coli-induced interleukin-8 production. J Enzyme Inhib Med Chem 2010 0.77
110 Metronidazole acid acyl sulfonamide: a novel class of anticancer agents and potential EGFR tyrosine kinase inhibitors. Bioorg Med Chem 2011 0.77
111 Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents. Eur J Med Chem 2011 0.77
112 Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents. Mini Rev Med Chem 2013 0.77
113 Oxadiazole derivatives containing 1,4-benzodioxan as potential immunosuppressive agents against RAW264.7 cells. Bioorg Med Chem 2011 0.77
114 Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Bioorg Med Chem Lett 2012 0.77
115 Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents. Bioorg Med Chem Lett 2011 0.77
116 Polycyclic aromatic hydrocarbons in surface sediments of the Jialu River. Ecotoxicology 2011 0.77
117 Photo-degradation of C.I. Disperse Blue 56 by UV irradiation combined with manganese minerals. Water Environ Res 2010 0.76
118 Synthesis and antitumor activity of 1,3,4-oxadiazole possessing 1,4-benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors. Bioorg Med Chem Lett 2013 0.76
119 Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity. Bioorg Med Chem 2013 0.76
120 Synthesis, molecular docking and biological evaluation of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents. Bioorg Med Chem 2012 0.76
121 Synthesis and antifungal activity of 1,2,3-triazole phenylhydrazone derivatives. Org Biomol Chem 2014 0.76
122 3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation. Bioorg Med Chem 2013 0.76
123 Nitroimidazoles as anti-tumor agents. Anticancer Agents Med Chem 2011 0.76
124 Discovery and synthesis of a novel series of potent, selective inhibitors of the PI3Kα: 2-alkyl-chromeno[4,3-c]pyrazol-4(2H)-one derivatives. Org Biomol Chem 2014 0.76
125 Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors. Bioorg Med Chem 2012 0.76
126 Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors. Bioorg Med Chem 2011 0.76
127 Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents. Bioorg Med Chem 2011 0.76
128 (E)-Ethyl 3-(2-fluoro-anilino)-2-(4-methoxy-phen-yl)acrylate. Acta Crystallogr Sect E Struct Rep Online 2008 0.75
129 3-(tert-But-oxy-carbon-yl)-2-(4-chloro-phen-yl)-1,3-thia-zolidine-4-carb-oxy-lic acid. Acta Crystallogr Sect E Struct Rep Online 2010 0.75
130 Fraxinellone. Acta Crystallogr Sect E Struct Rep Online 2011 0.75
131 (E)-4-[(3,5-Dimethyl-phen-yl)imino-meth-yl]-2-meth-oxy-3-nitro-phenol. Acta Crystallogr Sect E Struct Rep Online 2011 0.75
132 (E)-4-Chloro-benzyl 3-(3-nitro-benzyl-idene)dithio-carbazate. Acta Crystallogr Sect E Struct Rep Online 2009 0.75
133 Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors. Chem Pharm Bull (Tokyo) 2015 0.75
134 Design, synthesis, biological evaluation and molecular modeling of novel 1,3,4-oxadiazole derivatives based on Vanillic acid as potential immunosuppressive agents. Bioorg Med Chem 2012 0.75
135 3-(4-Acetoxy-phen-yl)-4-oxo-4H-1-benzopyran-5,7-diyl diacetate. Acta Crystallogr Sect E Struct Rep Online 2009 0.75
136 2,4-Diiodo-6-[(propyl-imino)-meth-yl]phenol. Acta Crystallogr Sect E Struct Rep Online 2012 0.75
137 (E)-Benzyl 3-(3-nitro-benzyl-idene)dithio-carbazate. Acta Crystallogr Sect E Struct Rep Online 2009 0.75
138 Synthesis, structure and antibacterial activity of potent DNA gyrase inhibitors: N'-benzoyl-3-(4-bromophenyl)-1H-pyrazole-5-carbohydrazide derivatives. PLoS One 2013 0.75
139 Synthesis, biological evaluation and molecular docking studies of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents. Bioorg Med Chem 2012 0.75
140 1-{2-[(4-Chloro-benzyl-idene)amino]phen-yl}-3-phenyl-thio-urea. Acta Crystallogr Sect E Struct Rep Online 2012 0.75
141 2-[(2-Chloro-phen-yl)imino-meth-yl]-4,6-di-iodo-phenol. Acta Crystallogr Sect E Struct Rep Online 2012 0.75
142 Synthesis and antiproliferative activities against Hep-G2 of salicylanide derivatives: potent inhibitors of the epidermal growth factor receptor (EGFR) tyrosine kinase. J Enzyme Inhib Med Chem 2010 0.75
143 2-[(4-Bromo-phenyl-imino)-meth-yl]-4,6-di-iodo-phenol. Acta Crystallogr Sect E Struct Rep Online 2012 0.75
144 6-Bromo-4-[(3-chloro-4-methyl-phenyl)-imino-meth-yl]-2-meth-oxy-3-nitro-phenol. Acta Crystallogr Sect E Struct Rep Online 2012 0.75
145 URD12: A urea derivative with marked antitumor activities. Oncol Lett 2011 0.75
146 Design, synthesis, antifungal, and antioxidant activities of (E)-6-((2-phenylhydrazono)methyl)quinoxaline derivatives. J Agric Food Chem 2014 0.75
147 Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents. Bioorg Med Chem 2010 0.75
148 Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors. Bioorg Med Chem 2013 0.75
149 Synthesis, inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease. J Enzyme Inhib Med Chem 2012 0.75
150 Potentiating 1-(2-hydroxypropyl)-2-styryl-5-nitroimidazole derivatives against antibacterial agents: design, synthesis and biology analysis. Eur J Med Chem 2013 0.75
151 Synthesis and crystal structures of ethanol-coordinated molybdenum(VI) oxo complexes with tridentate hydrazone ligands. Acta Chim Slov 2013 0.75
152 Discovery of 4,6-substituted-(diaphenylamino)quinazolines as potent c-Src inhibitors. Org Biomol Chem 2013 0.75
153 Synthesis, biological evaluation and molecular docking studies of novel 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone derivatives. Bioorg Med Chem 2012 0.75
154 Catena-poly[[silver(I)-mu-hexane-1,6-diamine-kappa2N:N'] cinnamate dihydrate]. Acta Crystallogr C 2004 0.75
155 Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors. Bioorg Med Chem Lett 2009 0.75
156 Interspecific competition between Microcystis aeruginosa and Anabaena flos-aquae from Taihu Lake, China. Z Naturforsch C 2014 0.75
157 Identification of novel 3,5-diarylpyrazoline derivatives containing salicylamide moiety as potential anti-melanoma agents. Bioorg Med Chem Lett 2012 0.75
158 Design, synthesis, and immunosuppressive activity of new deoxybenzoin derivatives. ChemMedChem 2010 0.75
159 Synthesis and antimicrobial activities of oximes derived from O-benzylhydroxylamine as FabH inhibitors. ChemMedChem 2012 0.75
160 Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors. Bioorg Med Chem Lett 2013 0.75
161 Activation of C-H bonds in nitrones leads to iridium hydrides with antitumor activity. J Med Chem 2013 0.75
162 Design, synthesis, and pharmacological investigation of iodined salicylimines, new prototypes of antimicrobial drug candidates. Arch Pharm (Weinheim) 2010 0.75
163 Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents. Bioorg Med Chem 2010 0.75
164 Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors. Bioorg Med Chem 2011 0.75
165 catena-Poly[[di-mu-benzoato-kappa4O:O'-disilver(I)]-mu-N,N'-bis(2-fluorobenzylidene)butane-1,4-diamine-kappa2N:N']. Acta Crystallogr C 2004 0.75
166 Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors. Bioorg Med Chem 2012 0.75
167 Synthesis and biological evaluation of novel N, N'-disubstituted urea and thiourea derivatives as potential anti-melanoma agents. J Enzyme Inhib Med Chem 2011 0.75
168 Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis. Eur J Med Chem 2013 0.75
169 Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Bioorg Med Chem 2011 0.75
170 Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors. Org Biomol Chem 2014 0.75
171 Synthesis, Crystal Structures and Urease Inhibition of N'-(2-Bromobenzylidene)-2-(4-nitrophenoxy) acetohydrazide and N'-(4-Nitrobenzylidene) -2-(4-nitrophenoxy)acetohydrazide. Acta Chim Slov 2015 0.75
172 Synthesis and characterization of the complexes of pentane-2,4-dione with nickel(II) and cobalt(III): [Ni(acac)2].0.5CH3OH and [Co(acac)2NO3].2H2O (acac = pentane-2,4-dione). Molecules 2004 0.75
173 Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2. Chem Pharm Bull (Tokyo) 2016 0.75
174 Targeted antimicrobial moieties (WO2010080819): patent evaluation. Expert Opin Ther Pat 2011 0.75
175 Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N'-phenylureas and thioureas as antitumor agents. Bioorg Med Chem 2009 0.75
176 Synthesis, crystal structure and immunosuppressive activity of acylamide derivatives containing 1,4-benzodioxan. ChemMedChem 2009 0.75
177 Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen Heterocycle as Potential β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) Inhibitors. Chem Pharm Bull (Tokyo) 2017 0.75
178 Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents. Bioorg Med Chem Lett 2010 0.75
179 catena-Poly[1,4-diazoniabicyclo[2.2.2]octane [silver(I)-tri-mu-thiocyanato-kappa6S:S]]. Acta Crystallogr C 2004 0.75
180 Discovery of Chromeno[4,3-c]pyrazol-4(2H)-one Containing Carbonyl or Oxime Derivatives as Potential, Selective Inhibitors PI3Kα. Chem Pharm Bull (Tokyo) 2016 0.75
181 Synthesis, biological evaluation and molecular modeling of dihydro-pyrazolyl-thiazolinone derivatives as potential COX-2 inhibitors. Bioorg Med Chem 2012 0.75
182 Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors. Bioorg Med Chem 2011 0.75
183 Novel topological index F based on incidence matrix. J Comput Chem 2003 0.75
184 Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors. Bioorg Med Chem 2010 0.75
185 Derivatives of resveratrol: potential agents in prevention and treatment of cardiovascular disease. Curr Med Chem 2012 0.75
186 Synthesis, molecular modeling and biological evaluation of PSB as targeted antibiotics. Bioorg Med Chem 2010 0.75
187 Synthesis, crystal structures, and antibacterial evaluation of metal complexes based on functionalized 2-phenylquinoline derivatives. Acta Chim Slov 2014 0.75
188 Synthesis, biological evaluation and molecular docking of novel 5-phenyl-1H-pyrazol derivatives as potential BRAF(V600E) inhibitors. Org Biomol Chem 2013 0.75
189 Design of novel N-phenylnicotinamides as selective cyclooxygenase-1 inhibitors. Bioorg Med Chem Lett 2010 0.75
190 Design and synthesis of fluoroacylshikonin as an anticancer agent. Chirality 2013 0.75
191 Synthesis and antimicrobical evaluation of a novel class of 1,3,4-thiadiazole: derivatives bearing 1,2,4-triazolo[1,5-a]pyrimidine moiety. Eur J Med Chem 2013 0.75
192 Design, synthesis, and biological evaluation of chalcone oxime derivatives as potential immunosuppressive agents. Bioorg Med Chem Lett 2012 0.75
193 Synthesis, biological evaluation and molecular docking studies of pyrazole derivatives coupling with a thiourea moiety as novel CDKs inhibitors. Eur J Med Chem 2013 0.75
194 Polymeric structure of (ethylenediamine)silver(I) 3-nitrobenzoate monohydrate. Acta Crystallogr C 2003 0.75
195 EGFR-binding peptide: a patent evaluation of WO2014002836. Expert Opin Ther Pat 2014 0.75
196 Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors. Bioorg Med Chem 2012 0.75
197 Synthesis, biological evaluation of chrysin derivatives as potential immunosuppressive agents. Eur J Med Chem 2010 0.75
198 Nitroimidazole derivatives: a patent review of US 2014/0141084 A1. Expert Opin Ther Pat 2015 0.75
199 Bis[mu-2-[3-(cyclohexylammonio)propyliminomethyl]phenolato]bis[dichlorocopper(II)]. Acta Crystallogr C 2004 0.75
200 A Quinoline-Based Ratiometric and Reversible Fluorescent Probe for Cadmium Imaging in Living Cells. Chem Pharm Bull (Tokyo) 2015 0.75
201 Synthesis, biological evaluation and molecular docking studies of flavone and isoflavone derivatives as a novel class of KSP (kinesin spindle protein) inhibitors. Eur J Med Chem 2013 0.75